Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Botulinum toxin in motor disorders.

A R Bentivoglio¹, A Albanese

¹Department of Neurology, Catholic University, Rome, Italy.

Current Opinion in Neurology

|November 11, 1999

Summary

Botulinum neurotoxin treatments are advancing for neurological conditions like focal dystonia and spasticity. New toxin types and combined therapies with rehabilitation show promise for improved clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate.

European journal of neurology·2026

Same author

Tau Disaggregation by a CNS-Permeable Small Molecule Reduces Fibril and Oligomer Burden and Preserves Proteostasis and Behavior.

bioRxiv : the preprint server for biology·2026

Same author

Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment.

Journal of endocrinological investigation·2024

Same author

Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease.

Neurologia·2023

Same author

The Minor's test in Frey syndrome treated with botulinum toxin: Methodology and efficacy.

American journal of otolaryngology·2023

Same author

Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease.

Neurologia·2021

Area of Science:

Neurology
Pharmacology

Background:

Clinical applications of botulinum neurotoxins are continuously evolving.
Neurologists are particularly interested in advanced treatments for focal dystonia and other movement disorders.

Purpose of the Study:

To review recent advancements in botulinum neurotoxin therapy.
To explore new developments in treating dyskinesias, smooth muscle motility, spasticity, and juvenile cerebral palsy.

Main Methods:

Review of current clinical practices and emerging research in botulinum neurotoxin therapy.
Investigation of novel toxin serotypes and their potential clinical impact.
Evaluation of combined focal chemodenervation with rehabilitation procedures.

Main Results:

New botulinum neurotoxin serotypes are under investigation, potentially enhancing clinical practice and enabling combination therapies.
Indications for spasticity and juvenile cerebral palsy are being actively examined.
Integrating focal chemodenervation with rehabilitation offers new therapeutic avenues.

Conclusions:

Ongoing research and development in botulinum neurotoxins are expanding treatment options for various neurological conditions.
The availability of new toxin serotypes and combined treatment strategies are poised to significantly improve patient care.
The synergy between focal chemodenervation and rehabilitation represents a promising frontier in neurological treatment.

Related Experiment Videos